Mirabegron

Mirabegron is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

It is commercialised in Europe by Astellas pharma as Betmiga.

Back to science »